Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients

Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients

Abstract Background Post-hospitalized acute coronary syndrome (ACS) patients in Indonesia National Insurance does not pay for the use of high-intensity statin (HIS) for secondary prevention after ACS hospitalization. Moreover, a cost–utility analysis needs to be conducted to evaluate the cost-effect...

Full description

Bibliographic Details
Main Authors: Pramitha Esha Nirmala Dewi, Montarat Thavorncharoensap, Bangunawati Rahajeng
Format: Article
Language:English
Published: SpringerOpen 2024-04-01
Series:The Egyptian Heart Journal
Subjects:
Acute coronary syndrome
Cost–utility analysis
High-intensity stain
Cost per quality-adjusted life year
Online Access:https://doi.org/10.1186/s43044-024-00478-2

Internet

https://doi.org/10.1186/s43044-024-00478-2

Similar Items